Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2023-10-04 Sale |
2023-10-06 7:18 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Epperly Melissa B Chief Financial Officer |
5,482 | $19.5 | $106,926 | 387,691 (Direct) |
View |
2023-09-11 Sale |
2023-09-13 4:11 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Skvarka Jan Director |
5,000 | $25.05 | $125,238 | 47,970 (Direct) |
View |
2023-06-20 Purchase |
2023-06-20 4:30 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Matrix Capital Management Company LP GOEL DAVID E. 10% Owner |
4,760,000 | $22.66 | $107,861,600 | 13,959,973 (Indirect) |
View |
2023-05-31 Sale |
2023-05-31 9:10 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Gallagher Cam President |
27,768 | $26.27 | $729,506 | 463,502 (Direct) |
View |
2023-05-26 Sale |
2023-05-31 9:09 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Bunker Kevin D. Chief Scientific Officer |
80,000 | $30.02 | $2,401,248 | 880,507 (Indirect Direct) |
View |
2023-02-13 Sale |
2023-02-14 7:10 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Epperly Melissa B Chief Financial Officer |
7,851 | $20.13 | $158,005 | 392,048 (Direct) |
View |
2023-02-13 Sale |
2023-02-14 7:09 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Gallagher Cam President |
11,833 | $20.09 | $237,760 | 491,270 (Direct) |
View |
2023-02-13 Sale |
2023-02-14 7:07 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Bunker Kevin D. Chief Scientific Officer |
10,307 | $20.14 | $207,629 | 960,507 (Indirect Direct) |
View |
2023-02-06 Sale |
2023-02-06 7:36 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Gallagher Cam President |
10,000 | $22.27 | $222,678 | 503,103 (Direct) |
View |
2023-01-17 Sale |
2023-01-18 5:15 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Gallagher Cam President |
10,000 | $24.15 | $241,515 | 352,011 (Direct) |
View |
2023-01-05 Sale |
2023-01-05 7:16 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Gallagher Cam President |
10,000 | $21.02 | $210,228 | 362,011 (Direct) |
View |
2022-11-15 Sale |
2022-11-15 7:50 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Gallagher Cam President |
12,500 | $22.77 | $284,683 | 372,011 (Direct) |
View |
2022-11-07 Sale |
2022-11-08 8:38 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Gallagher Cam President |
24,874 | $23.62 | $587,403 | 384,511 (Direct) |
View |
2022-10-17 Sale |
2022-10-17 9:02 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Gallagher Cam President |
12,500 | $23.51 | $293,879 | 409,385 (Direct) |
View |
2022-10-05 Sale |
2022-10-07 4:40 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Gallagher Cam President |
22,500 | $22.45 | $505,186 | 421,885 (Direct) |
View |
2022-09-15 Sale |
2022-09-16 8:25 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Gallagher Cam President |
22,500 | $24.9 | $560,254 | 444,385 (Direct) |
View |
2022-08-10 Sale |
2022-08-12 4:26 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Bunker Kevin D. Chief Operating Officer |
5,000 | $30 | $150,000 | 859,460 (Indirect Direct) |
View |
2022-07-20 Sale |
2022-07-20 8:28 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Bunker Kevin D. Chief Operating Officer |
5,000 | $30 | $150,000 | 864,460 (Indirect Direct) |
View |
2022-07-13 Sale |
2022-07-14 6:37 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Bunker Kevin D. Chief Operating Officer |
5,000 | $30.01 | $150,062 | 869,460 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2023-06-16 Option Award |
2023-06-16 5:04 pm |
N/A N/A |
Zentalis Pharmaceuticals Inc. | ZNTL | Johnson David Michael Director |
19,059 | $0 | 127,389 (Direct) |
View |
2023-06-16 Option Award |
2023-06-16 5:02 pm |
N/A N/A |
Zentalis Pharmaceuticals Inc. | ZNTL | Kariuki Enoch Director |
16,364 | $0 | 38,181 (Direct) |
View |
2023-06-16 Option Award |
2023-06-16 5:01 pm |
N/A N/A |
Zentalis Pharmaceuticals Inc. | ZNTL | Skvarka Jan Director |
16,364 | $0 | 52,970 (Direct) |
View |
2023-05-08 Option Award |
2023-05-10 07:13 am |
N/A N/A |
Zentalis Pharmaceuticals Inc. | ZNTL | HAUSMAN DIANA Director |
39,732 | $0 | 39,732 (Direct) |
View |
2023-03-01 Option Award |
2023-03-02 4:30 pm |
N/A 2033-03-01 |
Zentalis Pharmaceuticals Inc. | ZNTL | Roth Iris Chief Operating Officer |
350,000 | $0 | 350,000 (Direct) |
View |
2023-02-01 Option Award |
2023-02-01 7:09 pm |
N/A 2033-01-31 |
Zentalis Pharmaceuticals Inc. | ZNTL | Bunker Kevin D. Chief Scientific Officer |
224,000 | $0 | 1,103,460 (Direct) |
View |
2022-11-09 Gift |
2023-02-01 7:09 pm |
N/A N/A |
Zentalis Pharmaceuticals Inc. | ZNTL | Bunker Kevin D. Chief Scientific Officer |
30,000 | $0 | 1,103,460 (Direct) |
View |
2023-02-01 Option Award |
2023-02-01 7:08 pm |
N/A 2033-01-31 |
Zentalis Pharmaceuticals Inc. | ZNTL | Gallagher Cam President |
395,000 | $0 | 747,011 (Direct) |
View |
2023-02-01 Option Award |
2023-02-01 7:08 pm |
N/A 2033-01-31 |
Zentalis Pharmaceuticals Inc. | ZNTL | Blackwell Kimberly Chief Executive Officer |
600,000 | $0 | 605,000 (Direct) |
View |
2023-02-01 Option Award |
2023-02-01 7:07 pm |
N/A 2033-01-31 |
Zentalis Pharmaceuticals Inc. | ZNTL | Epperly Melissa B Chief Financial Officer |
250,000 | $0 | 547,942 (Direct) |
View |
2023-02-01 Option Award |
2023-02-01 7:06 pm |
N/A 2033-01-31 |
Zentalis Pharmaceuticals Inc. | ZNTL | Paul Andrea General Counsel |
100,000 | $0 | 100,000 (Direct) |
View |
2023-02-01 Option Award |
2023-02-01 7:06 pm |
N/A 2033-01-31 |
Zentalis Pharmaceuticals Inc. | ZNTL | Brownstein Carrie Chief Medical Officer |
40,000 | $0 | 140,000 (Direct) |
View |
2022-10-03 Option Award |
2022-10-03 6:42 pm |
N/A N/A |
Zentalis Pharmaceuticals Inc. | ZNTL | Epperly Melissa B Chief Financial Officer |
50,000 | $0 | 297,543 (Direct) |
View |
2022-10-03 Option Award |
2022-10-03 6:40 pm |
N/A 2032-10-02 |
Zentalis Pharmaceuticals Inc. | ZNTL | Bunker Kevin D. Chief Scientific Officer |
50,000 | $0 | 959,460 (Direct) |
View |
2022-10-03 Option Award |
2022-10-03 6:37 pm |
N/A 2032-10-02 |
Zentalis Pharmaceuticals Inc. | ZNTL | Brownstein Carrie Chief Medical Officer |
400,000 | $0 | 500,000 (Direct) |
View |
2022-09-09 Option Award |
2022-09-12 07:07 am |
N/A N/A |
Zentalis Pharmaceuticals Inc. | ZNTL | Skvarka Jan Director |
36,606 | $0 | 36,606 (Direct) |
View |
2022-08-01 Option Award |
2022-08-01 5:28 pm |
N/A 2032-07-31 |
Zentalis Pharmaceuticals Inc. | ZNTL | Paul Andrea General Counsel |
290,500 | $0 | 290,500 (Direct) |
View |